查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1387914

2024 年流感诊断全球市场报告

Influenza Diagnostic Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，流感诊断的市场规模一直强劲成长。将从2023年的25.9亿美元扩大到2024年的27.9亿美元，复合年增长率为7.6%。历史时期观察到的扩张是由于多种因素造成的，包括公共卫生意识的增强、技术的进步、抗病毒药物的开发以及对流行病预防的更加重视。

2023年流感诊断市场最大的地区是北美。西欧是流感诊断市场的第二大地区。流感诊断市场报告涵盖的地区包括亚太地区、西欧、东欧、北美、南美、中东和非洲。

目录

第一章执行摘要

第二章 流感诊断市场特点

第三章 流感诊断市场趋势与策略

第四章流感诊断市场-宏观经济情景

第五章 全球流感诊断市场规模与成长

  • 全球流感诊断市场的驱动与抑制因素
    • 市场驱动力
    • 市场抑制因素
  • 2018-2023年全球流感诊断市场规模实绩与成长
  • 全球流感诊断市场规模及成长预测，2023-2028、2033

第六章 流感诊断市场区隔

  • 全球流感诊断市场，依传统诊断测试细分、实绩与预测，2018-2023、2023-2028、2033
  • 流感快速诊断检验 (RIDT)
  • 病毒培养
  • DFA
  • 血清学检测
  • 其他常规诊断测试
  • 全球流感诊断市场，按分子诊断测试细分，实绩和预测，2018-2023、2023-2028、2033
  • 逆转录聚合酶连锁反应 (RT-PCR)
  • 恒温核酸增幅试验（INAAT）
  • 灯检测
  • 转录介导的等温扩增测定
  • 其他等恒温核酸增幅试验
  • 其他分子诊断测试
  • 全球流感诊断市场，按最终用户细分，实绩和预测，2018-2023、2023-2028、2033
  • 医院和临床实验室
  • 诊断标准研究所
  • 学术/研究机构
  • 其他最终用户

第七章流感诊断市场区域与国家分析

  • 全球流感诊断市场，按地区、实绩及预测，2018-2023、2023-2028、2033
  • 全球流感诊断市场，依国家、实绩及预测，2018-2023年、2023-2028、2033年

第八章亚太流感诊断市场

第九章 中国流感诊断市场

第十章 印度流感诊断市场

第十一章 日本流感诊断市场

第十二章 澳洲流感诊断市场

第十三章 印尼流感诊断市场

第十四章 韩国流感诊断市场

第十五章西欧流感诊断市场

第十六章英国流感诊断市场

第十七章 德国流感诊断市场

第十八章 法国流感诊断市场

第十九章 义大利流感诊断市场

第二十章 西班牙流感诊断市场

第21章 东欧流感诊断市场

第22章 俄罗斯流感诊断市场

第23章北美流感诊断市场

第24章美国流感诊断市场

第25章加拿大流感诊断市场

第26章南美流感诊断市场

第27章 巴西流感诊断市场

第28章 中东流感诊断市场

第29章 非洲流感诊断市场

第三十章 流感诊断市场竞争形势及企业概况

  • 流感诊断市场竞争形势
  • 流感诊断市场公司概况
    • F. Hoffmann-La Roche Ltd.
    • Quidel Corporation
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Hologic Inc.

第三十一章 全球流感诊断市场竞争基准化分析

第32章全球流感诊断市场竞争仪表板

第三十三章 流感诊断市场重大併购

第三十四章 流感诊断市场未来展望及可能性分析

第35章附录

简介目录
Product Code: r9156

“Influenza Diagnostic Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on influenza diagnostic market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for influenza diagnostic? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The influenza diagnostic market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT); Viral Culture; DFA; Serological assays; Other Traditional diagnostic tests
  • 2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR); Isothermal Nucleic Acid Amplification Tests (INAAT); Loop Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Transcription Mediated Isothermal Based Amplification Assays; Other Isothermal Nucleic Acid Amplification Tests; Other Molecular Diagnostic Tests
  • 3) By End User: Hospitals And Clinical Laboratories; Diagnostic Reference Laboratories; Academic/Research Institutes; Other End Users
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Quadell Corporation; Thermos Fisher Scientific Inc.; Abbott Laboratories; Hologic Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

The diagnosis of influenza, commonly known as the flu, involves employing various tests to detect the presence of the influenza virus. These diagnostic methods include viral culture, serology, rapid antigen testing, reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays. Influenza is caused by three primary types of the influenza virus such as type A, type B, and type C. Its symptoms typically include fever, sore throat, cough, body ache, fatigue, and headache. The market for influenza diagnostics encompasses the revenues generated by entities involved in conducting tests for the detection of the influenza virus.

The conventional diagnostic tests for influenza comprise rapid influenza diagnostic tests (RIDT), viral culture, DFA, serological assays, and other tests. Rapid influenza diagnostic tests (RIDTs) are immunoassays capable of identifying the presence of influenza A and B viral nucleoprotein antigens in respiratory samples, offering a qualitative outcome (positive or negative). Molecular diagnostic tests encompass a range of methods such as Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), loop-mediated isothermal-based amplification assays, transcription-mediated isothermal-based amplification assays, and other isothermal nucleic acid amplification tests. These tests are employed by hospitals, clinical laboratories, diagnostic reference laboratories, academic/research institutes, and other end users.

The influenza diagnostic market research report is one of a series of new reports from The Business Research Company that provides influenza diagnostic market statistics, including influenza diagnostic industry global market size, regional shares, competitors with a influenza diagnostic market share, detailed influenza diagnostic market segments, market trends and opportunities, and any further data you may need to thrive in the influenza diagnostic industry. This influenza diagnostic market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The influenza diagnostic market size has grown strongly in recent years. It will grow from $2.59 billion in 2023 to $2.79 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The expansion observed in the historic period can be credited to several factors including heightened public health awareness, advancements in technology, the development of antiviral medications, and an increased focus on pandemic preparedness.

The influenza diagnostic market size is expected to see strong growth in the next few years. It will grow to $3.68 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The projected growth in the forecast period can be linked to several factors, notably the persistent occurrence of seasonal influenza, the rise in point-of-care testing, increased adoption of remote and home testing, and the integration of digital health solutions. Noteworthy trends anticipated in this period encompass the prevalence of point-of-care testing, the utilization of molecular diagnostics, the development of antigen-based tests, the emergence of multiplex assays, and the implementation of automation and robotics within the industry.

The future growth of the influenza diagnostic market is anticipated to be significantly driven by the increasing prominence of rapid diagnostic tests. These tests are medical tools used to confirm or rule out illnesses, and rapid influenza diagnostic tests (RIDTs) specifically can detect influenza viral antigens in approximately 10-15 minutes, albeit with moderate sensitivity ranging from 50-70%. As per the data from the US-based Centers for Disease Control and Prevention (CDC) spanning from September 2020 to May 2021, out of 818,939 respiratory specimens tested by clinical laboratories in the United States, only 1,675 (0.2%) were positive for an influenza virus. This underscores the pivotal role of rapid diagnostic tests in propelling the influenza diagnostic market growth.

A pivotal driving factor for the market is the augmented funding for influenza diagnostics research. Effectively addressing the public health impact of influenza necessitates an in-depth understanding of the virus and its effects on individuals and communities. Accelerating scientific research progress is crucial for significant public health outcomes. Both public and private health organizations, researchers, health professionals, and biopharmaceutical companies have amplified their expenditure on research funds or grants to mitigate the risks associated with pandemic influenza. Notably, in April 2021, the National Institute of Allergy and Infectious Diseases (NIAID), a segment of the National Institutes of Health, allocated $24 million in funding to support five Centres of Excellence for Influenza Research and Response (CEIRR), including one at St. Jude Children's Research Hospital. A substantial portion of the federal contract's initial year's funding, totaling over $8.9 million for St. Jude's research, was directed toward the enhanced understanding, prediction, tracking, and treatment of emerging influenza and other viruses.

The market's growth is being restrained due to the variability in sensitivity and specificity among various influenza diagnostic tests. In many rapid flu tests, there are challenges in accurately identifying patients with influenza, as their sensitivity ranges widely from 10-80% across different patient groups. Most diagnostic tests exhibit an increased rate of false-negative results during periods of low influenza virus activity, leading to potential misdiagnoses. Consequently, the variability in sensitivity and specificity among these tests is impeding the growth of the influenza diagnostic market.

Key players in the influenza diagnostic market are actively innovating and developing groundbreaking products like the Lucira COVID-19 & Flu Home Test, allowing rapid simultaneous qualitative detection. This single-use at-home test kit enables users to obtain results from self-collected nasal swab samples in approximately 30 minutes. An example of such innovation is the approval received by Pfizer Inc., a US-based pharmaceutical company, in February 2023 for the Lucira by Pfizer COVID-19 & Flu Home Test. This test is capable of detecting both influenza A and B (commonly known as the flu) and SARS-CoV-2, the virus responsible for COVID-19.

The utilization of rapid influenza diagnostic tests (RIDTs) in influenza diagnostics is increasingly prevalent. RIDTs, which are immunoassays, identify the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens, providing a qualitative result (positive or negative). These tests deliver outcomes within a clinically relevant timeframe of approximately 15 minutes and are particularly effective in diagnosing patients with influenza-like symptoms, especially within the first four days of symptom onset. The growing favor for RIDTs is attributed to their user-friendly nature and swift diagnostic capabilities.

In February 2021, Thermo Fisher Scientific Inc., a US-based company specializing in clinical development, completed the acquisition of Mesa Biotech, Inc. for an undisclosed sum. This strategic acquisition is aimed at enhancing manufacturing capacity, achieving cost efficiencies, and expediting the delivery of vital diagnostics to the market on a larger scale. Mesa Biotech, Inc. is a US-based company focusing on infectious disease diagnostics.

Major companies operating in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMerieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd.

North America was the largest region in the influenza diagnostics market in 2023. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the influenza diagnostic market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The influenza diagnostic market includes revenue earned by test kit and reagents, and other products. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Influenza Diagnostic Market Characteristics

3. Influenza Diagnostic Market Trends And Strategies

4. Influenza Diagnostic Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Influenza Diagnostic Market Size and Growth

  • 5.1. Global Influenza Diagnostic Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Influenza Diagnostic Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Influenza Diagnostic Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Influenza Diagnostic Market Segmentation

  • 6.1. Global Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Rapid Influenza Diagnostic Tests (RIDT)
  • Viral Culture
  • DFA
  • Serological Assays
  • Other Traditional Diagnostic Tests
  • 6.2. Global Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Reverse Transcription Polymerase Chain Reaction (RT-PCR)
  • Isothermal Nucleic Acid Amplification Tests (INAAT)
  • Loop Mediated Isothermal Based Amplification Assays
  • Transcription Mediated Isothermal Based Amplification Assays
  • Transcription Mediated Isothermal Based Amplification Assays
  • Other Isothermal Nucleic Acid Amplification Tests
  • Other Molecular Diagnostic Tests
  • 6.3. Global Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals And Clinical Laboratories
  • Diagnostic Reference Laboratories
  • Academic/Research Institutes
  • Other End Users

7. Influenza Diagnostic Market Regional And Country Analysis

  • 7.1. Global Influenza Diagnostic Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Influenza Diagnostic Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Influenza Diagnostic Market

  • 8.1. Asia-Pacific Influenza Diagnostic Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Influenza Diagnostic Market

  • 9.1. China Influenza Diagnostic Market Overview
  • 9.2. China Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Influenza Diagnostic Market

  • 10.1. India Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Influenza Diagnostic Market

  • 11.1. Japan Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.2. Japan Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Influenza Diagnostic Market

  • 12.1. Australia Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Influenza Diagnostic Market

  • 13.1. Indonesia Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Influenza Diagnostic Market

  • 14.1. South Korea Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.2. South Korea Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Influenza Diagnostic Market

  • 15.1. Western Europe Influenza Diagnostic Market Overview
  • 15.2. Western Europe Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Influenza Diagnostic Market

  • 16.1. UK Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Influenza Diagnostic Market

  • 17.1. Germany Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Influenza Diagnostic Market

  • 18.5. France Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.6. France Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.7. France Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Influenza Diagnostic Market

  • 19.9. Italy Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.10. Italy Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.11. Italy Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Influenza Diagnostic Market

  • 20.13. Spain Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.14. Spain Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Influenza Diagnostic Market

  • 21.1. Eastern Europe Influenza Diagnostic Market Overview
  • 21.2. Eastern Europe Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Influenza Diagnostic Market

  • 22.1. Russia Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Influenza Diagnostic Market

  • 23.1. North America Influenza Diagnostic Market Overview
  • 23.2. North America Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Influenza Diagnostic Market

  • 24.1. USA Influenza Diagnostic Market Overview
  • 24.2. USA Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Influenza Diagnostic Market

  • 25.1. Canada Influenza Diagnostic Market Overview
  • 25.2. Canada Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Influenza Diagnostic Market

  • 26.1. South America Influenza Diagnostic Market Overview
  • 26.2. South America Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Influenza Diagnostic Market

  • 27.1. Brazil Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Influenza Diagnostic Market

  • 28.1. Middle East Influenza Diagnostic Market Overview
  • 28.2. Middle East Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Influenza Diagnostic Market

  • 29.1. Africa Influenza Diagnostic Market Overview
  • 29.2. Africa Influenza Diagnostic Market, Segmentation By Traditional Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Influenza Diagnostic Market, Segmentation By Molecular Diagnostic Tests, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Influenza Diagnostic Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Influenza Diagnostic Market Competitive Landscape And Company Profiles

  • 30.1. Influenza Diagnostic Market Competitive Landscape
  • 30.2. Influenza Diagnostic Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Quidel Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abbott Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Hologic Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Influenza Diagnostic Market Competitive Benchmarking

32. Global Influenza Diagnostic Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Influenza Diagnostic Market

34. Influenza Diagnostic Market Future Outlook and Potential Analysis

  • 34.1 Influenza Diagnostic Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Influenza Diagnostic Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Influenza Diagnostic Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer